Measurements of serial plasma levels of albumin mRNA for management of patients post transplant: Does it add value?

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1311-1312

  Selzner, Nazia ^a   Levy, Gary ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SERUM ALBUMIN;

ACUTE GRAFT REJECTION; ALBUMIN BLOOD LEVEL; BACTERIAL INFECTION; CHOLESTASIS; CHRONIC PATIENT; DIABETES MELLITUS; EDITORIAL; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; LIVER DISEASE; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; NONALCOHOLIC FATTY LIVER; PATIENT MONITORING; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; VIRUS INFECTION;

CHOLANGITIS; FEMALE; GRAFT REJECTION; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; RNA, MESSENGER; SERUM ALBUMIN;

EID: 84884346465     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.09.001     Document Type: Editorial

References (17)

1. Hong H., Goodsaid F., Shi L., Tong W. Molecular biomarkers: a US FDA effort. Biomar Med 2010, 2:215-225.
2. Keown P.A., McMaster W.R., McManus B.M. Tools to identify organ rejection and immune quiescence for biological understanding and personalized medical care. Biomark Med 2010, 4:115-121.
3. Pradat P., Alberti A., Poynard T., Esteban J.I., Weiland O., et al. Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative Study. Hepatology 2002, 36:973-977.
4. Kamm R.C., Smith A.G. Nucleic acid concentration in normal human plasma. Clin Chem 1972, 18:519-522.
5. Stroun M., Anker P., Maurice P., Gahan P.B. Circulating nucleic acids in higher organisms. Int Rev Cytol 1977, 51:1-48.
6. Ng E.K., Tsui N.B., Lam N.Y., et al. Presence of filterable and non filterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002, 48:1212-1217.
7. Tsui N.B., Ng E.K., Lo Y.M. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 2002, 48:147-153.
8. Lauschke H., Caspari R., Friedl W., Schwarz B., Mathiak M., Propping P., et al. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer. Cancer Detect Prev 2001, 25:55-61.
9. Chen X., Bonnefoi H., Diebold-Berger S., Lyautey J., Lederrey C., Faltin-Traub E., et al. Detecting tumor related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res 1999, 5:2297-2303.
10. Miyakis S., Spandidos D.A. Allelic loss in breast cancer. Cancer Detect Prev 2002, 26:426-434.
11. Okochi O., Hibi K., Uemura T., Inoue S., Takeda S., Kaneko T., et al. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res 2002, 8:2875-2878.
12. Wing Yan Chan R., Wong J., Bo Shan lai P., Ming Dennis Lo Y., Chiu R.W. The potential clinical utility of serial plasma albumin mRNA monitoring for the post liver transplantation management. Clin Biochem 2013, 46:1313-1319.
13. Chan R.W., Wong J., Chan H.L., Mok T.S., Lo W.Y., Lee V. Aberrant concentrations of liver-derived plasma albumin mRNA in liver pathologies. Clin Chem 2010, 5:82-89.
14. Lucey M., Terrault N., Ojo L., Hay J., Neuberger J., Blumberg E., et al. Long term management of the successful adult liver transplant. Liver Transpl 2013, 19:3-26.
15. Steer C.J., Subramanian S. Circulating microRNAs as biomarkers: a new frontier in diagnostics. Liver Transpl 2012, 18:265-269.
16. Farid W.R.R., Pan Q., van der Meer A.J.P., de Ruiter P., et al. Hepatocyte derived micro RNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 2012, 18:290-297.
17. Cermelli S., Ruggieri A., Marrero J.A., Joannou G.N., et al. Circulating microRNAs in patients with chronic hepatitis C and non alcoholic fatty liver disease. PLoS One 2011, e23937.